H Oster

Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Fourth Universal Definition of Myocardial Infarction (2018)

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Prospects for Cardiovascular Research

Evolving Therapies for Myocardial Ischemia/Reperfusion Injury

Use of doping agents, particularly anabolic steroids, in sports and society

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Myocardial ischemia-reperfusion injury: a neglected therapeutic target

Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

Checking consistency in mixed treatment comparison meta‐analysis

Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: Ten years' experience

Role of Oxidative Modifications in Atherosclerosis

Postconditioning and protection from reperfusion injury: where do we stand? * Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

Thrombolytic Therapy: Current Status

Myocardial Reperfusion Injury

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

Antithrombotic Therapy for Venous Thromboembolic Disease

Intracoronary Urokinase in Kawasaki Disease: Treatment and Prevention of Myocardial Infarction

Arterial thrombosis—insidious, unpredictable and deadly

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder

Thrombosis as an intravascular effector of innate immunity

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

Advances in Thrombolytic Therapy

Angiographic features of the coronary arteries during intracoronary thrombolysis.

Intracoronary Fibrinolytic Therapy in Acute Myocardial Infarction

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Plasminogen Activators, Tissue Degradation, and Cancer

Coronary Thrombolysis for Evolving Myocardial Infarction

Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction

Coronary thrombolysis: Pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA)

The stunned myocardium: prolonged, postischemic ventricular dysfunction.

An Update on Cardiac Enzymes

Efforts to Limit the Size of Myocardial Infarcts

Intracoronary infusion of streptokinase in patients with acute myocardial infarction: Effects of reperfusion on left ventricular performance

Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart

Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study.

Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction

Long-term Consequences of Kawasaki Disease

Aortocoronary Saphenous Vein Graft Disease

Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.

Fourth Universal Definition of Myocardial Infarction (2018)

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION

Fourth universal definition of myocardial infarction (2018)

Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardium

Unstable angina and evolving myocardial infarction following coronary bypass surgery: Pathogenesis and treatment with interventional catheterization

EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION

Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.

Clinicopathologic correlates of acute ischemic heart disease syndromes

Improved nanoindentation and microwave shielding properties of modified MWCNT reinforced polyurethane composites

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Effect of Intravenous Streptokinase on Acute Myocardial Infarction

Intracoronary thrombolysis in evolving myocardial infarction

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Selected topics in biomedical polyurethanes. A review

Creatine and Creatinine Metabolism

Meta-analysis in clinical trials

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.

Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

Recanalization of an acutely occluded aortocoronary bypass by intragraft fibrinolysis.

Thrombus generation within the artificial heart

Wiedereröffnung des Infarktgefäßes durch transluminale Rekanalisation und intrakoronare Streptokinase-Applikation